Should You Buy BIO-TECHNE Corp (TECH) Stock After it Has Risen 5.14% in a Week?

Friday, May 27, 2022 01:03 PM | InvestorsObserver Analysts

Mentioned in this article

Overall market sentiment has been high on BIO-TECHNE Corp (TECH) stock lately. TECH receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

BIO-TECHNE Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TECH!
See Full TECH Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With TECH Stock Today?

BIO-TECHNE Corp (TECH) stock is trading at $385.18 as of 12:49 PM on Friday, May 27, a rise of $19.86, or 5.44% from the previous closing price of $365.32. The stock has traded between $368.63 and $386.29 so far today. Volume today is light. So far 73,144 shares have traded compared to average volume of 256,176 shares. To see InvestorsObserver's Sentiment Score for BIO-TECHNE Corp click here.

More About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Click Here to get the full Stock Report for BIO-TECHNE Corp stock.

Share this article:

Related Articles